Myeloid-derived suppressor cell heterogeneity and subset definition

被引:538
|
作者
Peranzoni, Elisa [2 ]
Zilio, Serena [2 ]
Marigo, Ilaria [2 ]
Dolcetti, Luigi [1 ,3 ]
Zanovello, Paola [1 ,2 ]
Mandruzzato, Susanna [1 ,2 ]
Bronte, Vincenzo [1 ,3 ]
机构
[1] IRCCS, IOV, I-35128 Padua, Italy
[2] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy
[3] Venetian Inst Mol Med, Padua, Italy
关键词
CARCINOMA PATIENTS; CANCER-PATIENTS; BONE-MARROW; T-CELLS; MONOCYTES; BLOOD; MACROPHAGE; DIFFERENTIATION; IDENTIFICATION; MECHANISM;
D O I
10.1016/j.coi.2010.01.021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid derived suppressor cells (MDSCs) are defined in mice on the basis of CD11b and Gr-1 marker expression and the functional ability to inhibit T lymphocyte activation. Nevertheless the term 'heterogeneous' remains the first, informal feature commonly attributed to this population. It is clear that CD11b Gr-1 cells are part of a myeloid macropopulation, which comprises at least two subsets of polymorphonuclear and monocytic cells with different immunosuppressive properties. While recent literature shows substantial agreement on the immunoregulatory property of the monocytic MDSC subset, there is still contrasting evidence on the role of the granulocytic fraction. Moreover, this dichotomy holds true for human MDSCs. We attempt here to summarize conflicting findings in the field and provide some possible, unifying explanations.
引用
收藏
页码:238 / 244
页数:7
相关论文
共 50 条
  • [1] Myeloid-derived suppressor cell heterogeneity in human cancers
    Solito, Samantha
    Marigo, Ilaria
    Pinton, Laura
    Damuzzo, Vera
    Mandruzzato, Susanna
    Bronte, Vincenzo
    YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION, 2014, 1319 : 47 - 65
  • [2] Myeloid-derived suppressor cell subset heterogeneity drives glioblastoma progression in a sex-dependent manner
    Bayik, Defne
    Zhou, Yadi
    Park, Chihyun
    Hong, Changjin
    Vail, Daniel
    Silver, Daniel J.
    Lauko, Adam J.
    Roversi, Gustavo A.
    Watson, Dionysios C.
    Lo, Alice
    Alban, Tyler J.
    McGraw, Mary
    Sorensen, Mia D.
    Grabowski, Matthew M.
    Otvos, Balint
    Vogelbaum, Michael A.
    Horbinski, Craig M.
    Khalil, Ahmad M.
    Hwang, Tae Hyun
    Ahluwalia, Manmeet S.
    Cheng, Feixiong
    Lathia, Justin D.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [3] Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma
    Sato, Yusuke
    Shimizu, Kanako
    Shinga, Jun
    Hidaka, Michihiro
    Kawano, Fumio
    Kakimi, Kazuhiro
    Yamasaki, Satoru
    Asakura, Miki
    Fujii, Shin-ichiro
    ONCOIMMUNOLOGY, 2015, 4 (03): : 1 - 10
  • [4] Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells
    Donkor, Moses K.
    Lahue, Elaine
    Hoke, Traci A.
    Shafer, Laura R.
    Coskun, Ugur
    Solheim, Joyce C.
    Gulen, Dumrul
    Bishay, John
    Talmadge, James E.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (7-8) : 937 - 948
  • [5] Myeloid-derived suppressor cells
    Nagaraj, Srinivas
    Gabrilovich, Dmitry I.
    IMMUNE-MEDIATED DISEASES: FROM THEORY TO THERAPY, 2007, 601 : 213 - 223
  • [6] Myeloid-Derived Suppressor Cells
    Gabrilovich, Dmitry I.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (01) : 3 - 8
  • [7] Myeloid-Derived Suppressor Cells
    Woodland, David L.
    VIRAL IMMUNOLOGY, 2017, 30 (02) : 81 - 81
  • [8] Mechanism of Myeloid-Derived Suppressor Cell Differentiation in Cancer
    Gabrilovich, Dmitry
    BLOOD, 2009, 114 (22) : 1582 - 1582
  • [9] Recent advances in myeloid-derived suppressor cell biology
    Yaseen, Mahmoud Mohammad
    Abuharfeil, Nizar Mohammad
    Darmani, Homa
    Daoud, Ammar
    FRONTIERS OF MEDICINE, 2021, 15 (02) : 232 - 251
  • [10] Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
    Hao, Zhaonian
    Li, Ruyuan
    Wang, Yuanyuan
    Li, Shuangying
    Hong, Zhenya
    Han, Zhiqiang
    BIOMARKER RESEARCH, 2021, 9 (01)